BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 14750238)

  • 1. Expression of bcl-6 and CD10 protein is associated with longer overall survival and time to treatment failure in follicular lymphoma.
    Bilalovic N; Blystad AK; Golouh R; Nesland JM; Selak I; Trinh D; Torlakovic E
    Am J Clin Pathol; 2004 Jan; 121(1):34-42. PubMed ID: 14750238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of PU.1 in follicular lymphoma.
    Torlakovic EE; Bilalovic N; Golouh R; Zidar A; Angel S
    J Pathol; 2006 Jul; 209(3):352-9. PubMed ID: 16639693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma.
    Muris JJ; Meijer CJ; Vos W; van Krieken JH; Jiwa NM; Ossenkoppele GJ; Oudejans JJ
    J Pathol; 2006 Apr; 208(5):714-23. PubMed ID: 16400625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of inflammatory cytokines at diagnosis correlate to the bcl-6 and CD10 defined germinal centre (GC) phenotype and bcl-2 expression in patients with diffuse large B-cell lymphoma.
    Pedersen LM; Jürgensen GW; Johnsen HE
    Br J Haematol; 2005 Mar; 128(6):813-9. PubMed ID: 15755285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pattern and frequency of t(14;18) translocation and immunophenotype in Asian follicular lymphoma.
    Peh SC; Shaminie J; Tai YC; Tan J; Gan SS
    Histopathology; 2004 Nov; 45(5):501-10. PubMed ID: 15500654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD5+ follicular lymphoma: a clinicopathologic study of three cases.
    Barry TS; Jaffe ES; Kingma DW; Martin AW; Sorbara L; Raffeld M; Pittaluga S
    Am J Clin Pathol; 2002 Oct; 118(4):589-98. PubMed ID: 12375647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCL-6 expression predicts improved survival in patients with primary central nervous system lymphoma.
    Braaten KM; Betensky RA; de Leval L; Okada Y; Hochberg FH; Louis DN; Harris NL; Batchelor TT
    Clin Cancer Res; 2003 Mar; 9(3):1063-9. PubMed ID: 12631608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of the bcl6 and CD10 proteins is associated with increased apoptosis and proliferation in diffuse large B-cell lymphomas.
    Bai M; Agnantis NJ; Skyrlas A; Tsanou E; Kamina S; Galani V; Kanavaros P
    Mod Pathol; 2003 May; 16(5):471-80. PubMed ID: 12748254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD10 and Bcl-2 expression combined with the International Prognostic Index can identify subgroups of patients with diffuse large-cell lymphoma with very good or very poor prognoses.
    Biasoli I; Morais JC; Scheliga A; Milito CB; Romano S; Land M; Pulcheri W; Spector N
    Histopathology; 2005 Mar; 46(3):328-33. PubMed ID: 15720419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of bcl-2 in classical Hodgkin's lymphoma: an independent predictor of poor outcome.
    Sup SJ; Alemañy CA; Pohlman B; Elson P; Malhi S; Thakkar S; Steinle R; Hsi ED
    J Clin Oncol; 2005 Jun; 23(16):3773-9. PubMed ID: 15809450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased CD10 expression in grade III and in interfollicular infiltrates of follicular lymphomas.
    Eshoa C; Perkins S; Kampalath B; Shidham V; Juckett M; Chang CC
    Am J Clin Pathol; 2001 Jun; 115(6):862-7. PubMed ID: 11392883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8+ T-cell content in diagnostic lymph nodes measured by flow cytometry is a predictor of survival in follicular lymphoma.
    Wahlin BE; Sander B; Christensson B; Kimby E
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):388-97. PubMed ID: 17255259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD23 expression in follicular lymphoma: clinicopathologic correlations.
    Olteanu H; Fenske TS; Harrington AM; Szabo A; He P; Kroft SH
    Am J Clin Pathol; 2011 Jan; 135(1):46-53. PubMed ID: 21173123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial features and outcome of cutaneous and non-cutaneous primary extranodal follicular lymphoma.
    Fernández de Larrea C; Martínez-Pozo A; Mercadal S; García A; Gutierrez-García G; Valera A; Ghita G; Colomo L; Gainza E; Villamor N; Nomdedeu B; Estrach T; Montserrat E; Campo E; López-Guillermo A
    Br J Haematol; 2011 May; 153(3):334-40. PubMed ID: 21375524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma.
    Gulmann C; Espina V; Petricoin E; Longo DL; Santi M; Knutsen T; Raffeld M; Jaffe ES; Liotta LA; Feldman AL
    Clin Cancer Res; 2005 Aug; 11(16):5847-55. PubMed ID: 16115925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab.
    Natkunam Y; Farinha P; Hsi ED; Hans CP; Tibshirani R; Sehn LH; Connors JM; Gratzinger D; Rosado M; Zhao S; Pohlman B; Wongchaowart N; Bast M; Avigdor A; Schiby G; Nagler A; Byrne GE; Levy R; Gascoyne RD; Lossos IS
    J Clin Oncol; 2008 Jan; 26(3):447-54. PubMed ID: 18086797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients.
    Plancarte F; López-Guillermo A; Arenillas L; Montoto S; Giné E; Muntañola A; Ferrer A; Villamor N; Bosch F; Colomo L; Balaguer O; Campo E; Montserrat E
    Eur J Haematol; 2006 Jan; 76(1):58-63. PubMed ID: 16343272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PU.1 protein expression has a positive linear association with protein expression of germinal centre B cell genes including BCL-6, CD10, CD20 and CD22: identification of PU.1 putative binding sites in the BCL-6 promotor.
    Torlakovic E; Malecka A; Myklebust JH; Tierens A; Aasheim HC; Nesland JM; Smeland E; Kvaløy S; Delabie J
    J Pathol; 2005 Jul; 206(3):312-9. PubMed ID: 15892171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follicular lymphoma of the duodenum: a clinicopathologic analysis of 26 cases.
    Sentani K; Maeshima AM; Nomoto J; Maruyama D; Kim SW; Watanabe T; Kobayashi Y; Tobinai K; Matsuno Y
    Jpn J Clin Oncol; 2008 Aug; 38(8):547-52. PubMed ID: 18687756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.